Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Williams

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Biochemical Society Transactions|January 16, 2009
Evolution and assembly of ESCRTsSara Ghazi-Tabatabai, Takayuki Obita, Ajaybabu V Pobbati, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Paradoxical dominant negative activity of an immunodeficiency-associated activating <i>PIK3R1</i> variantPatsy R Tomlinson, Rachel Knox, Olga Perisic, et al.
The Biochemical Journal|December 16, 2014
The function of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) explored using a specific inhibitor that targets the PI5P-binding siteJonathan H Clarke, Maria-Luisa Giudici, John E Burke, et al.
Biochemical Society Symposium|January 20, 2007
Structural studies of phosphoinositide 3-kinase-dependent traffic to multivesicular bodiesDavid J Gill, Hsiangling Teo, Ji Sun, et al.
The AAPS Journal|April 25, 2012
Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the AmericasRaimar Löbenberg, Nadia B Chacra, Erika S Stippler, et al.
Molecular Cell|January 25, 2011
Molecular and structural basis of ESCRT-III recruitment to membranes during archaeal cell divisionRachel Y Samson, Takayuki Obita, Ben Hodgson, et al.
Cell|April 18, 2006
ESCRT-I core and ESCRT-II GLUE domain structures reveal role for GLUE in linking to ESCRT-I and membranesHsiangling Teo, David J Gill, Ji Sun, et al.
Molecular Cell|March 3, 2011
Structure of lipid kinase p110β/p85β elucidates an unusual SH2-domain-mediated inhibitory mechanismXuxiao Zhang, Oscar Vadas, Olga Perisic, et al.
AAPS Pharmscitech|January 10, 2009
Change in criteria for USP dissolution performance verification testsWalter W Hauck, Anthony J DeStefano, William E Brown, et al.
FEBS Letters|November 26, 2013
Structural and mutational analysis reveals that CTNNBL1 binds NLSs in a manner distinct from that of its closest armadillo-relative, karyopherin αKaruna Ganesh, Febe van Maldegem, Stephanie B Telerman, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Biochemical Society Transactions|January 16, 2009
Evolution and assembly of ESCRTsSara Ghazi-Tabatabai, Takayuki Obita, Ajaybabu V Pobbati, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Paradoxical dominant negative activity of an immunodeficiency-associated activating <i>PIK3R1</i> variantPatsy R Tomlinson, Rachel Knox, Olga Perisic, et al.
The Biochemical Journal|December 16, 2014
The function of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) explored using a specific inhibitor that targets the PI5P-binding siteJonathan H Clarke, Maria-Luisa Giudici, John E Burke, et al.
Biochemical Society Symposium|January 20, 2007
Structural studies of phosphoinositide 3-kinase-dependent traffic to multivesicular bodiesDavid J Gill, Hsiangling Teo, Ji Sun, et al.
The AAPS Journal|April 25, 2012
Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the AmericasRaimar Löbenberg, Nadia B Chacra, Erika S Stippler, et al.
Molecular Cell|January 25, 2011
Molecular and structural basis of ESCRT-III recruitment to membranes during archaeal cell divisionRachel Y Samson, Takayuki Obita, Ben Hodgson, et al.
Cell|April 18, 2006
ESCRT-I core and ESCRT-II GLUE domain structures reveal role for GLUE in linking to ESCRT-I and membranesHsiangling Teo, David J Gill, Ji Sun, et al.
Molecular Cell|March 3, 2011
Structure of lipid kinase p110β/p85β elucidates an unusual SH2-domain-mediated inhibitory mechanismXuxiao Zhang, Oscar Vadas, Olga Perisic, et al.
AAPS Pharmscitech|January 10, 2009
Change in criteria for USP dissolution performance verification testsWalter W Hauck, Anthony J DeStefano, William E Brown, et al.
FEBS Letters|November 26, 2013
Structural and mutational analysis reveals that CTNNBL1 binds NLSs in a manner distinct from that of its closest armadillo-relative, karyopherin αKaruna Ganesh, Febe van Maldegem, Stephanie B Telerman, et al.
Pageof 13